Helen Torley
CIK 1528185 · PRESIDENT AND CEO · last filed 2026-06-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.27M
Companies
4
Total Filings
116
Lifetime Open-Market Net
-$87.67M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HTI | PRESIDENT AND CEO | 767,780 | — | — | -$83.25M | 89 | 2026-06-03 |
| DGX | Director | 6,260 | $203.06 | $1.27M | $0 | 7 | 2021-05-25 |
| Relypsa Inc (RLYP) Delisted | Director | 0 | — | — | -$19.6K | 5 | 2016-09-02 |
| ONYX PHARMACEUTICALS INC (ONXX) Delisted | EVP, Chief Commercial Officer | 35,911 | — | — | -$4.40M | 14 | 2013-09-05 |
Recent Filings · Page 12 of 12
116 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-09-06 | ONYX PHARMACEUTICALS INC (ONXX) Delisted | Sell (S) | −1,878 | -$136.7K | EDGAR |
| 2012-08-08 | ONYX PHARMACEUTICALS INC (ONXX) Delisted | Sell (S) | −2,000 | -$143.8K | EDGAR |
| 2012-07-27 | ONYX PHARMACEUTICALS INC (ONXX) Delisted | Sell (S) | −4,549 | -$336.5K | EDGAR |
| 2012-04-03 | ONYX PHARMACEUTICALS INC (ONXX) Delisted | Grant (A) | +20,750 | $0 | EDGAR |
| 2011-10-27 | ONYX PHARMACEUTICALS INC (ONXX) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
| 2011-08-31 | ONYX PHARMACEUTICALS INC (ONXX) Delisted | Grant (A) | +34,500 | $0 | EDGAR |
Showing 111–116 of 116
Prev
Page 12 of 12
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.